Literature DB >> 30409691

Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study.

Katherine A Sauder1, Jeanette M Stafford2, Elizabeth J Mayer-Davis3, Elizabeth T Jensen4, Sharon Saydah5, Amy Mottl6, Lawrence M Dolan7, Richard F Hamman8, Jean M Lawrence9, Catherine Pihoker10, Santica Marcovina11, Ralph B D'Agostino2, Dana Dabelea12.   

Abstract

BACKGROUND: One in three adolescents and young adults with type 1 diabetes have at least one early diabetes-related complication or comorbidity. We aimed to examine the prevalence and pattern of co-occurring complications in this population, as well as the related risk factors.
METHODS: This observational cohort study includes data from individuals diagnosed with type 1 diabetes before age 20 years who participated in the SEARCH for Diabetes in Youth Study across five sites in the USA. We assessed sociodemographic and metabolic risk factors at baseline and at follow-up, and diabetes complications at follow-up. A frequency analysis was done to examine the difference in observed versus expected prevalence (calculated using a contingency table assuming independence across cells) of co-occurring complications or comorbidities. A cluster analysis was done to identify unique clusters of participants based on demographic characteristics and metabolic risk factors.
FINDINGS: 1327 participants who completed the follow-up visit were included in the frequency analysis. The mean age was 10·1 (SD 3·9) years at the time of type 1 diabetes diagnosis and 18·0 (4·1) years at follow-up. At a mean diabetes duration of 7·8 [SD 1·9] years, co-occurrence of any two or more complications was observed in 78 (5·9%) participants, more frequently than expected by chance alone (58 [4·4%], p=0·015). Specifically, the complications that co-occurred more frequently than expected were retinopathy and diabetic kidney disease (11 [0·8%] vs three [0·2%]; p=0·0007), retinopathy and arterial stiffness (13 [1·0%] vs four [0·3%]; p=0·0016), and arterial stiffness and cardiovascular autonomic neuropathy (24 [1·8%] vs 13 [1·0%]; p=0·015). We identified four unique clusters characterised by progressively worsening metabolic risk factor profiles (longer duration of diabetes and higher glycated haemoglobin, non-HDL cholesterol, and waist-to-height ratio). The prevalence of at least two complications increased across the clusters (six [2·3%] of 261 in the low-risk cluster, 32 [6·3%] of 509 in the moderate-risk cluster, 28 [8%] of 348 in the high-risk cluster, and five [20·8%] of 24 in the highest-risk cluster). Compared with the low-risk and moderate-risk clusters, the high-risk and highest-risk clusters were characterised by a lower proportion of participants who were non-Hispanic white, and a higher proportion of participants who had a household income below US$50 000 and did not have private health insurance.
INTERPRETATION: Early complications co-occur in adolescents and young adults with type 1 diabetes more frequently than expected. Identification of individuals with adverse risk factors could enable targeted behavioural or medical interventions that reduce the likelihood of early development of lifelong diabetes-related morbidity. FUNDING: US Centers for Disease Control and Prevention, US National Institutes of Health.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30409691      PMCID: PMC6295346          DOI: 10.1016/S2352-4642(18)30309-2

Source DB:  PubMed          Journal:  Lancet Child Adolesc Health        ISSN: 2352-4642


  29 in total

1.  Triopathy of diabetes; sequence of neuropathy, retinopathy, and nephropathy in one hundred fifty-five patients.

Authors:  H F ROOT; W H POTE; H FREHNER
Journal:  AMA Arch Intern Med       Date:  1954-12

2.  Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.

Authors:  Ezio Bonifacio; Liping Yu; Alastair K Williams; George S Eisenbarth; Polly J Bingley; Santica M Marcovina; Kerstin Adler; Anette G Ziegler; Patricia W Mueller; Desmond A Schatz; Jeffrey P Krischer; Michael W Steffes; Beena Akolkar
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

3.  Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

Authors: 
Journal:  Diabet Med       Date:  2006-08       Impact factor: 4.359

4.  The prevalence of multiple diabetes-related complications.

Authors:  C L Morgan; C J Currie; N C Stott; M Smithers; C C Butler; J R Peters
Journal:  Diabet Med       Date:  2000-02       Impact factor: 4.359

5.  Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.

Authors:  Maria Nordwall; Lars Hyllienmark; Johnny Ludvigsson
Journal:  J Pediatr Endocrinol Metab       Date:  2006-01       Impact factor: 1.634

6.  Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.

Authors:  E Zander; I Seidlein; S Herfurth; P Heinke; R Chlup; K Badendick; J Strese; G Zander; B Schulz
Journal:  Exp Clin Endocrinol       Date:  1992

7.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

8.  A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.

Authors:  B S Olsen; A Sjølie; P Hougaard; J Johannesen; K Borch-Johnsen; K Marinelli; B Thorsteinsson; S Pramming; H B Mortensen
Journal:  J Diabetes Complications       Date:  2000 Nov-Dec       Impact factor: 2.852

9.  Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

Authors:  Christophe E M De Block; Ivo H De Leeuw; Luc F Van Gaal
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

10.  Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

Authors:  Klemens Raile; Angela Galler; Sabine Hofer; Antje Herbst; Desiree Dunstheimer; Petra Busch; Reinhard W Holl
Journal:  Diabetes Care       Date:  2007-07-13       Impact factor: 19.112

View more
  13 in total

1.  Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.

Authors:  Pattara Wiromrat; Petter Bjornstad; Carlos Roncal; Laura Pyle; Richard J Johnson; David Z Cherney; Tyler Lipina; Franziska Bishop; David M Maahs; R Paul Wadwa
Journal:  J Diabetes Complications       Date:  2019-06-03       Impact factor: 2.852

Review 2.  Diabetes in Youth: A Global Perspective.

Authors:  Anna R Kahkoska; Dana Dabelea
Journal:  Endocrinol Metab Clin North Am       Date:  2021-07-13       Impact factor: 4.748

Review 3.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

4.  Longitudinal Phenotypes of Type 1 Diabetes in Youth Based on Weight and Glycemia and Their Association With Complications.

Authors:  Anna R Kahkoska; Crystal T Nguyen; Linda A Adair; Allison E Aiello; Kyle S Burger; John B Buse; Dana Dabelea; Lawrence M Dolan; Faisal S Malik; Amy K Mottl; Catherine Pihoker; Beth A Reboussin; Katherine A Sauder; Michael R Kosorok; Elizabeth J Mayer-Davis
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 6.134

Review 5.  Twenty years of pediatric diabetes surveillance: what do we know and why it matters.

Authors:  Dana Dabelea; Katherine A Sauder; Elizabeth T Jensen; Amy K Mottl; Alyssa Huang; Catherine Pihoker; Richard F Hamman; Jean Lawrence; Lawrence M Dolan; Ralph D' Agostino; Lynne Wagenknecht; Elizabeth J Mayer-Davis; Santica M Marcovina
Journal:  Ann N Y Acad Sci       Date:  2021-02-05       Impact factor: 6.499

6.  The Impact of Racial and Ethnic Health Disparities in Diabetes Management on Clinical Outcomes: A Reinforcement Learning Analysis of Health Inequity Among Youth and Young Adults in the SEARCH for Diabetes in Youth Study.

Authors:  Anna R Kahkoska; Teeranan Pokaprakarn; G Rumay Alexander; Tessa L Crume; Dana Dabelea; Jasmin Divers; Lawrence M Dolan; Elizabeth T Jensen; Jean M Lawrence; Santica Marcovina; Amy K Mottl; Catherine Pihoker; Sharon H Saydah; Michael R Kosorok; Elizabeth J Mayer-Davis
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 17.152

7.  Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice.

Authors:  Hong Zheng; Pengtao Xu; Qiaoying Jiang; Qingqing Xu; Yafei Zheng; Junjie Yan; Hui Ji; Jie Ning; Xi Zhang; Chen Li; Limin Zhang; Yuping Li; Xiaokui Li; Weihong Song; Hongchang Gao
Journal:  Microbiome       Date:  2021-06-25       Impact factor: 14.650

Review 8.  Preventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach.

Authors:  Scott T Chiesa; M Loredana Marcovecchio
Journal:  Front Pediatr       Date:  2021-06-09       Impact factor: 3.418

9.  Progression to hypertension in youth and young adults with type 1 or type 2 diabetes: The SEARCH for Diabetes in Youth Study.

Authors:  Corinna Koebnick; Giuseppina Imperatore; Elizabeth T Jensen; Jeanette M Stafford; Amy S Shah; Amy K Mottl; Ronny A Bell; Dana Dabelea; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Elaine M Urbina; Jean M Lawrence
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-15       Impact factor: 2.885

10.  Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood.

Authors:  Michael R Kosorok; Elizabeth J Mayer-Davis; Anna R Kahkoska; Crystal T Nguyen; Xiaotong Jiang; Linda A Adair; Shivani Agarwal; Allison E Aiello; Kyle S Burger; John B Buse; Dana Dabelea; Lawrence M Dolan; Giuseppina Imperatore; Jean Marie Lawrence; Santica Marcovina; Catherine Pihoker; Beth A Reboussin; Katherine A Sauder
Journal:  BMJ Open Diabetes Res Care       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.